Furthermore, hepatic C16:0 content was related with hepatic steatosis or inflammation and hepatic SCD-1 could convert C16:0 to C18:1 to reduce the toxicity of C16:0 [35,36]. The gene discussed is SCD; the disease is fatty liver disease.